StonvexLoading…
StonvexCore line items from FHN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-14 | Q2 2024 2024-06-30 | Q2 2023 2023-06-30 |
|---|---|---|---|
Revenue | $892.75M | $9.00M | $9.00M |
Operating Income | Not available | $514.00M | $756.00M |
Net Income | Not available | $391.00M | $576.00M |
EPS (Diluted) | $0.53 | $0.67 | $1.00 |
Total Assets | Not available | $82.23B | $85.07B |
Total Liabilities | Not available | $73.28B | $76.11B |
Cash & Equivalents | Not available | $1.46B | $1.42B |
Free Cash Flow OCF − CapEx | Not available | $667.00M | Not available |
Shares Outstanding | Not available | 552.54M | 562.19M |